35.15USD+0.98%Mkt Cap: 5.98B USDP/E: —Last update: 2026-06-01
Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyros…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap5.98B USD
Enterprise Value5.41B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-328.94M USD
Revenue/Share—
Last Price35.15 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees258
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-36.45
PEG—
EV/EBITDA-15.05
EV/Revenue—
P/S—
P/B11.00
EPS (TTM)-2.17
EPS (Forward)-0.96
52W Range
5.10078% of range43.73
52W High43.73 USD
52W Low5.100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-51.69%
ROA-35.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-264.44M USD
CapEx (TTM)1.55M USD
FCF Margin—
FCF Yield-2.80%
Net Debt-627.72M USD
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.38
Current Ratio15.14
Quick Ratio14.94
Book Value/Sh3.178 USD
Cash/Share5.069 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 9, 2020
Splits
Last Split1:4
Split DateNov 9, 2020
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)54.25 USD
Target Range35.00 USD – 72.00 USD
# Analysts12
Ownership
Shares Out.170.87M
Float160.86M
Insiders0.43%
Institutions112.12%
Short Interest
Short Ratio7.2d
Short % Float6.57%
Short % Out.6.53%
Shares Short11.16M
Short (prev mo.)12.04M
Technical
SMA 5035.38 (-0.6%)
SMA 20029.52 (+19.1%)
Beta0.37
S&P 52W Chg27.94%
Avg Vol (30d)1.56M
Avg Vol (10d)2.20M
Technical Indicators
RSI (14)51.7
MACD-0.4663
MACD Signal-0.7264
MACD Hist.+0.2600
BB Upper37.54 USD
BB Middle34.24 USD
BB Lower30.94 USD
BB Width19.29%
ATR (14)1.381 USD
Vol Ratio (20d)0.64x